BioSpace News Archive

Business

HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance

Total revenue for the fourth quarter of 2017 is expected to be between $6.9 and $7.2 million, an increase of 373% to 394% over the fourth quarter of 2016.

January 4, 2018
·
6 min read
Drug Development

Catalyst Biosciences Initiates Phase II/III Trial of Marzeptacog Alfa (activated) for Prophylaxis in Hemophilia A or B With Inhibitors

This Phase 2 open-label, subcutaneous efficacy trial in individuals with hemophilia A or B with inhibitors will evaluate the ability of MarzAA to eliminate, or minimize, spontaneous bleeding episodes.

January 4, 2018
·
4 min read
Drug Development

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress

A look at the accomplishments that occurred during the fourth quarter of 2017.

January 4, 2018
·
8 min read
BioMidwest

PTS Diagnostics Announces New Retail Point-of-Care Software

Unlike other data capture systems, PTS Connect ProLink delivers a personalized wellness report through wireless technology.

January 4, 2018
·
3 min read
Biotech Beach

Torrey Pines Launches i2020 Accelerator for Early Therapeutics

Torrey Pines Investment announced today the launch and initial funding of its i2020 Accelerator initiative.

January 4, 2018
·
1 min read
Sealantis Receives CE Marking for Seal-G Surgical Sealant for GI Procedures

The CE will allow to market the product in the Europe and additional other countries.

January 4, 2018
·
2 min read
Business

Rexahn Pharmaceuticals Announces the Appointment of Douglas J. Swirsky as President and Chief Financial Officer

Mr. Swirsky was most recently President, CEO and a director of GenVec.

January 4, 2018
·
4 min read
Toshiba Medical Systems Officially Becomes Canon Medical Systems

Canon announced that the change of the company name enters into effect today.

January 4, 2018
·
3 min read
Business

Triumvira Names a New CEO

Dr. Lammers brings more than 27 years of experience in product and clinical development spanning the pharmaceutical and biotechnology industries.

January 4, 2018
·
3 min read
Business

Adaptive Biotechnologies Announces Partnership with Microsoft to Decode the Human Immune System to Improve the Diagnosis of Disease

Adaptive Biotechnologies announced today their partnership with Microsoft to map the genetics of the human immune system, or immunome, in order to detect cancers and other diseases in their earliest stage, when they can be more effectively treated.

January 4, 2018
·
4 min read